HIV antigen-anti-CD40 fusion protein vaccine (Baylor Scott & White Research Institute/ANRS)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHIV antigen-anti-CD40 fusion protein vaccine (Baylor Scott & White Research Institute/ANRS)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant protein > Fusion protein +[4]

Mechanisms of ActionGlycosaminoglycan modulatorsTumor necrosis factor receptor superfamily member 5 modulatorsProtein Nef modulators

TargetsProtein NefGlycosaminoglycanTumor necrosis factor receptor superfamily member 5

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBaylor Scott & White Research Institute

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAgence Nationale de Recherches sur le Sida et les hepatites virales (ANRS)Baylor Scott & White Research Institute

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A